Editorial Open Access
Artificial intelligence and the depersonalization of medicine
Barry Swerdlow1,*
- 1Oregon Health & Science University, 3455 SW US Veterans Hospital Rd, Rm 517 Portland, OR 97239, USA
Corresponding Author
Barry Swerdlow, swerdlow@ohsu.edu
Received Date: February 25, 2026
Accepted Date: February 27, 2026
Swerdlow B. Artificial intelligence and the depersonalization of medicine. J Clin Anesth Intensive Care. 2026;6(1):6-7.
Copyright: © 2026 Swerdlow B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Healthcare professionals’ awareness and knowledge of COVID-19 and radiation safety
Background: lack of knowledge and awareness of COVID-19 and radiation safety among healthcare professionals will adversely affect their health and the patients’ safety due to unnecessary radiation exposure and rapid spread of COVID-19. The purpose of this study is to evaluate the knowledge and the awareness of both domains; COVID-19 and radiation awareness in one survey study.
Logic model of a case management program in primary care for frequent users of healthcare services
A logic model was developed as part of an evaluation of a case management program (CMP) for frequent users in a health and social services center in the province of Québec (Canada). Five approaches were used as part of a qualitative multiple case study methodology: analysis of unpublished documents, review of literature on CMPs for frequent users, in-depth interviews, focus groups with stakeholders and participant observations.
Dynamics of the ‘free’ maternal healthcare policy intervention in Ghana; Facility delivery utilization and neonatal mortality indices from a developing country setting
The one conceptual key to improving newborn healthcare outcomes is thought to be bridging the access gap to care, particularly in sub-Saharan Africa. However, recent studies have reported conflicting results relative to establishing a link between outcomes and access to care intervention programs.
Artificial intelligence and the future of transfusion medicine
Transfusion Medicine (TM) is a relatively young medical discipline supporting a large number of medical specialties on an almost daily basis. In de routine of TM large amounts of data are collected and processed in a standardized way and depending on the economy of scale practiced. Blood and its components are not without risk when transfused.
Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine
Lung cancer is the leading cause of cancer death among both men and women in the United States. Because lung cancer is genetically heterogeneous, tailored therapy alone or in combination with chemotherapy would increase patient overall survival as compared with the one-size-fits-all chemotherapy. TP53-mutant lung cancer accounts for more than half of all lung cancer cases and is oftentimes more aggressive and resistant to chemotherapy. Directly targeting mutant p53 has not yet been successful, so identification of novel therapy targets and biomarkers in the TP53-mutant lung cancer is urgently needed to increase the overall survival in this subgroup.